These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 33096920)
41. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy. Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245 [TBL] [Abstract][Full Text] [Related]
42. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883 [TBL] [Abstract][Full Text] [Related]
43. Regulation of alternative splicing in Drosophila by 56 RNA binding proteins. Brooks AN; Duff MO; May G; Yang L; Bolisetty M; Landolin J; Wan K; Sandler J; Booth BW; Celniker SE; Graveley BR; Brenner SE Genome Res; 2015 Nov; 25(11):1771-80. PubMed ID: 26294686 [TBL] [Abstract][Full Text] [Related]
44. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116 [TBL] [Abstract][Full Text] [Related]
45. Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Aartsma-Rus A; Kaman WE; Weij R; den Dunnen JT; van Ommen GJ; van Deutekom JC Mol Ther; 2006 Sep; 14(3):401-7. PubMed ID: 16753346 [TBL] [Abstract][Full Text] [Related]
46. Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles. Sironi M; Cagliani R; Comi GP; Pozzoli U; Bardoni A; Giorda R; Bresolin N FEBS Lett; 2003 Feb; 537(1-3):30-4. PubMed ID: 12606026 [TBL] [Abstract][Full Text] [Related]
47. When a mid-intronic variation of DMD gene creates an ESE site. Trabelsi M; Beugnet C; Deburgrave N; Commere V; Orhant L; Leturcq F; Chelly J Neuromuscul Disord; 2014 Dec; 24(12):1111-7. PubMed ID: 25193336 [TBL] [Abstract][Full Text] [Related]
53. Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping. Maruyama R; Yokota T Methods Mol Biol; 2018; 1828():165-171. PubMed ID: 30171541 [TBL] [Abstract][Full Text] [Related]
54. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy. Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660 [TBL] [Abstract][Full Text] [Related]
55. rMAPS: RNA map analysis and plotting server for alternative exon regulation. Park JW; Jung S; Rouchka EC; Tseng YT; Xing Y Nucleic Acids Res; 2016 Jul; 44(W1):W333-8. PubMed ID: 27174931 [TBL] [Abstract][Full Text] [Related]
56. Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice. Hiller M; Spitali P; Datson N; Aartsma-Rus A Methods Mol Biol; 2018; 1828():249-262. PubMed ID: 30171546 [TBL] [Abstract][Full Text] [Related]
57. Pseudoexons of the DMD Gene. Keegan NP J Neuromuscul Dis; 2020; 7(2):77-95. PubMed ID: 32176650 [TBL] [Abstract][Full Text] [Related]
58. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538 [TBL] [Abstract][Full Text] [Related]
59. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5. Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656 [TBL] [Abstract][Full Text] [Related]
60. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation. Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]